Editorial & Advertiser disclosure

Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Headlines

Novo Nordisk said to make higher bid for Metsera to challenge Pfizer, Bloomberg News reports

Published by Global Banking & Finance Review

Posted on October 30, 2025

1 min read

· Last updated: January 21, 2026

Add as preferred source on Google

Novo Nordisk said to make higher bid for Metsera to challenge Pfizer, Bloomberg News reports

innovation financial community corporate strategy

Global Banking & Finance Awards 2026 — Call for Entries

(Reuters) -Danish drugmaker Novo Nordisk has made a higher offer for Metsera seeking to trump an agreed deal with Pfizer so it can consolidate its position in weight-loss medications, Bloomberg News

Novo Nordisk said to make higher bid for Metsera to challenge Pfizer, Bloombe...

Novo Nordisk's Strategic Move in the Pharmaceutical Market

(Reuters) -Danish drugmaker Novo Nordisk has made a higher offer for Metsera seeking to trump an agreed deal with Pfizer so it can consolidate its position in weight-loss medications, Bloomberg News reported on Thursday citing people with knowledge of the matter.

Details of the Bid

(Reporting by Sriparna Roy in Bengaluru; Editing by Mrigank Dhaniwala)

Key Takeaways

Novo Nordisk has increased its bid for Metsera.
The move is aimed at challenging Pfizer's existing deal.
Novo Nordisk seeks to strengthen its weight-loss medication market.
The news was reported by Bloomberg citing insider sources.
This strategic bid highlights competition in pharmaceuticals.

Frequently Asked Questions

What is a bid?

A bid is an offer made by an individual or company to purchase an asset or service at a specified price. In finance, bids are often used in auctions or competitive purchasing situations.

What is a pharmaceutical market?

The pharmaceutical market refers to the industry involved in the research, development, production, and marketing of medications. It includes both prescription and over-the-counter drugs.

What is weight-loss medication?

Weight-loss medications are drugs designed to help individuals lose weight by suppressing appetite, increasing feelings of fullness, or reducing absorption of calories. They are often prescribed alongside lifestyle changes.

More from Headlines

Explore more articles in the Headlines category

Northern Ireland police investigate car explosion as attempted murder

UK says cooperating closely with US on security ahead of King Charles' visit

Israeli attacks kill at least four Palestinians in Gaza, medics say

Six passengers injured evacuating from Swiss Air flight in India, Economic Times says

Trump removed from White House correspondents dinner as attendees take cover

Car explodes outside police station in Northern Ireland, Belfast Telegraph reports

US-Iran peace hopes fade as Trump scraps talks

Ukraine marks 40th anniversary of Chornobyl disaster under cloud of war

Russia's parliamentary speaker visits Pyongyang, KCNA says

Probe of stolen $1 billion should continue after conviction of Moldovan magnate, top official says

Swimming-Finland joins hosting boycott over World Aquatics decision on Russia

Iran says it will not accept 'maximalist' US demands as Pakistan pursues peace

View All Headlines Posts

Novo Nordisk said to make higher bid for Metsera to challenge Pfizer, Bloomberg News reports

Novo Nordisk said to make higher bid for Metsera to challenge Pfizer, Bloombe...

Novo Nordisk's Strategic Move in the Pharmaceutical Market

Details of the Bid

Key Takeaways

Frequently Asked Questions

Tags

Related Articles

Netanyahu's biggest rivals join forces for Israel's next election

Israel issues evacuation warning for seven Lebanese towns beyond 'buffer zone'

Athletics-Kenya's Sawe shatters elusive two-hour marathon barrier to win in London

UK's Starmer and Trump discuss 'urgent need' to restore shipping in Strait of Hormuz

Pope Leo says those who wage war are thieves stealing away our peaceful future

King Charles relieved Trump and first lady unharmed after shooting

More from Headlines